Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01780220
What this trial is testing

Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following Surgery

Who this might be right for
Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy
UNICANCER 47
Early research (Phase 1)Study completedNCT02514213
What this trial is testing

Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer

Who this might be right for
Prostate Cancer
Inovio Pharmaceuticals 62
Large-scale testing (Phase 3)UnknownNCT00764166
What this trial is testing

A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel

Who this might be right for
Adenocarcinoma of the Prostate
Assistance Publique - Hôpitaux de Paris 254
Not applicableStudy completedNCT00668083
What this trial is testing

Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
AstraZeneca 214
Testing effectiveness (Phase 2)Study completedNCT00908141
What this trial is testing

GM-CSF in Treating Patients With Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 17
Large-scale testing (Phase 3)Study completedNCT00283062
What this trial is testing

Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy

Who this might be right for
Prostatic Neoplasms
Sanofi 228
Testing effectiveness (Phase 2)Study completedNCT01787331
What this trial is testing

Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate CarcinomaStage I Prostate Adenocarcinoma AJCC v7+2 more
University of California, San Francisco 21
Testing effectiveness (Phase 2)Study completedNCT03490032
What this trial is testing

68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa)

Who this might be right for
Prostate Cancer Metastatic
Advanced Accelerator Applications 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03795207
What this trial is testing

Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736)

Who this might be right for
Node; ProstateBone MetastasesProstate Cancer Patients
Institut Cancerologie de l'Ouest 96
Not applicableLooking for participantsNCT06546267
What this trial is testing

Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 2,500
Testing effectiveness (Phase 2)Ended earlyNCT00482274
What this trial is testing

Docetaxel in Treating Patients With Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 3
Early research (Phase 1)Looking for participantsNCT07488923
What this trial is testing

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

Who this might be right for
Small Cell Lung Cancer (SCLC )Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)Gastroenteropancreatic NEC (GEP NEC)+1 more
Moonlight Bio, Inc 110
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07189871
What this trial is testing

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more
Radiopharm Theranostics, Ltd 61
Large-scale testing (Phase 3)Ended earlyNCT00705822
What this trial is testing

Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Sanofi 54
Not applicableUnknownNCT02935816
What this trial is testing

Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniques

Who this might be right for
Prostate Cancer
University College, London 130
Testing effectiveness (Phase 2)Study completedNCT01588821
What this trial is testing

Cabozantinib in Advanced Solid Malignancies

Who this might be right for
Lung CancerSolid Tumor (Not Breast or Prostate Cancers)
Massachusetts General Hospital 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT00859781
What this trial is testing

177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 55
Large-scale testing (Phase 3)Not Yet RecruitingNCT07782112
What this trial is testing

Best Salvage Treatment for High-risk Relapsing Prostate Cancer (PEACE-9 - ESCALATE-RT)

Who this might be right for
Prostatic NeoplasmsBiochemical RecurrenceOligometastatic Prostate Cancer
Ente Ospedaliero Cantonale, Bellinzona 140
Early research (Phase 1)Study completedNCT03205176
What this trial is testing

AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas

Who this might be right for
Malignant Solid TumorsLymphomaOvarian Cancer+3 more
AstraZeneca 49
Next Page